Peel Hunt Reaffirms Buy Rating for Craneware (CRW)
Separately, N+1 Singer reissued a hold rating on shares of Craneware in a research report on Tuesday, September 5th.
Shares of Craneware (LON:CRW) opened at GBX 1,530 ($20.46) on Wednesday. The company has a market capitalization of $411.39 and a price-to-earnings ratio of 4,250.00. Craneware has a 12-month low of GBX 1,165 ($15.58) and a 12-month high of GBX 1,885 ($25.20).
Craneware plc is a United Kingdom-based company, which is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company’s Value Cycle Solutions span over five product families, which include Patient Engagement, Charge Capture & Pricing, Coding Integrity, Cost Analytics, and Revenue Collection & Retention.
Receive News & Stock Ratings for Craneware Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware and related stocks with our FREE daily email newsletter.